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Coronary1. Introduction
Ventricular premature contractions (VPC) refractory to medical
management may require catheter ablation for symptomatic
beneﬁt or for compromised ventricular function in the setting of a
high VPC burden [1,2]. While most VPCs are amenable to catheter
ablation with conventional radiofrequency or cryothermal ablation
from an endocardial approach, 8% of VPCs will have an intramural
origin [3].Where endocardial and epicardial approaches have failed
to eliminate the VPC, intramural sources may require alternative
approaches such as intra-coronary ethanol ablation [4]. We present
a novel series of three intra-coronary ethanol ablation procedures
in two patients with symptomatic VPCs and normal ventricular
function.Abbreviations: VPC, Ventricular premature contraction; EPS, Electrophysiology
study; LVEF, Left ventricular ejection fraction.
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2.1. Patient selection & prior procedures
The two patients underwent three ethanol ablation procedures
for symptomatic VPCs between November 2014 and September
2015. Prior to the ethanol ablation procedures the two patients had
undergone conventional electrophysiology study (EPS) and abla-
tion from both endocardial and epicardial approaches, and
following these procedures an intramural origin was presumed in
both patients. The prior EPS had been performed under conscious
sedation with CARTO3, contact force sensing catheters (Thermo-
cool SmartTouch®, Biosense Webster, Diamond Bar, CA, USA), and
an Agilis sheath (St Jude Medical, St. Paul, MN, USA). Both patients
had no other comorbidities and had trialled multiple anti-
arrhythmic medications (three and ﬁve anti-arrhythmic medica-
tions in patients 1 and 2 respectively) to suppress the VPCs. Both
patients had undergone cardiac MRI and transthoracic echocar-
diogram pre procedure conﬁrming normal ventricular function
(left ventricular ejection fraction of 55% and 57% in patients 1 and 2
respectively) with no late gadolinium enhancement, and had un-
dergone serial electrocardiography and Holter monitoring
demonstrating frequent monomorphic ventricular ectopy (30% and
32% burden of VPCs respectively).
2.2. Electrophysiology study
Both patients presented with frequent symptomatic ventricular
ectopy on the day of the ethanol ablation procedure (Figs. 1 and 2).
Prior to ethanol ablation, electrophysiology studies were per-
formed under conscious sedation with local anaesthetic and anti-
arrhythmic medications had been withheld for 5 half-lives before
the procedure. Vascular access was obtained using ultrasound
guidance, and included 7F and 8F sheaths to the right femoral vein
and an 8F sheath to the right femoral artery. Therapeutic anti-
coagulation with heparin was administered and monitored
throughout the case. Electroanatomic Mapping using CARTO3 and
Thermocool SmartTouch® catheter (Biosense Webster) was per-
formed initially via the right femoral vein for right ventricular and
coronary sinus mapping and subsequently via a retrograde leftElsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. Patient 1; left panel sinus rhythm and ventricular premature contraction morphology (VPC); middle panel wire provoked VT in the 3rd septal perforator (arrow), also note QS
morphology of unipolar electrogram fromwire (25 ms pre QRS); right panel shows pace-map from 3rd septal perforator; inset representative wire position on coronary angiogram
with ablator at earliest endocardial site.
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ping. In both patients the activation timing relative to the ectopic
QRS was not signiﬁcantly early at any endocardial site (Fig. 3),
including within the coronary venous system selectively engaged
with an SL4 sheath (St JudeMedical), Left Internal Mammary Artery
(LIMA) guiding catheter and guide-wire for mapping. Subsequently
intra-coronary mapping was pursued.
2.3. Intra-coronary mapping and ethanol ablation
Immediately prior to intra-coronary mapping coronary angi-
ography was performed with JL4 and JR4 catheters, demonstrating
no coronary disease in both patients. A 0.014 inch Balance Middle
Weight guidewire (BMW, Abbott Vascular, Illinois, USA) was
advanced through the JL4 guide catheter, and an over-the-wire
(OTW) balloon (1.25  8mm) was advanced over the BMW guide-
wire leaving the distal tip of the guidewire exposed. The proximal
end of the BMW guidewire was connected to the positive port of a
pacing module, and the negative port was connected to a quad-
ripolar catheter placed in the inferior vena cava, creating a unipole
for activation mapping. The BMW guidewire was sequentially
advanced into different septal branches of the left anterior
descending artery to observe activation timing during VPCs.
After a suitable septal perforator had been identiﬁed, the OTW
balloon was advanced into the perforator so that its tip lay just
beyond the ostium of the vessel and selective angiography was
performed, conﬁrming no backﬂow of contrast into the proximal
left anterior descending artery and no collaterals. Cold saline (5mL)
was injected down the branch to assess for suppression of the VPC.
Once a suitable branch was identiﬁed, agitated gelo-plasma wasinjected to highlight which region of the left ventricle was supplied
by this branch on contrast echocardiography. Neat ethanol
(1e1.5mL) was administered down the relevant branch with the
OTW balloon inﬂated (to 10 atm) for 5 min before being deﬂated.
Patients were monitored with telemetry in hospital for a further 24
hours and underwent Holter monitoring at 6 months post pro-
cedure, with clinical review at 3,6 and 12 months.
2.4. Procedural details
In Patient 1 the earliest site on endocardial and coronary sinus
mapping was identiﬁed at the mid-septum, but was only 5 ms pre-
VPC QRS onset. The ablation catheter was left at this site as a
radiographic marker. During intracoronary mapping, the ﬁrst two
septal perforators were not signiﬁcantly early to the onset of the
VPC. However, when the BMW guidewire was advanced into the
3rd septal perforator, ventricular tachycardia (VT) was induced
with an excellent match to the clinical VPC. The unipolar electro-
gram was 25 ms pre-QRS onset with a QS morphology suggesting
activation away from this site (Fig. 1). With the 1.25  8mm OTW
balloon inﬂated, 5mL of cold saline injected through the balloon
terminated VT. Upon deﬂation of the balloon and rewarming, VT
recommenced and further cold saline again terminated VT. Pace
mapping from the guidewire in the 3rd septal perforator gave a
good match to the clinical VPC (Fig. 1). Prior to ethanol adminis-
tration agitated gelo-plasma through the balloon highlighted only
one segment of the LV in the mid-interventricular septum on
contrast transthoracic echocardiography. With the balloon inﬂated,
ethanol (1mL) was injected with transient ST elevation in V2 and
V3. After ethanol administration the ST elevation resolved, VPCs
Fig. 2. Patient 2 procedure 2; left panel sinus rhythm and ventricular premature contraction morphology (VPC); middle panel VPC with intracoronary wire in proximal septal
branch, note QS morphology of unipolar electrogram fromwire is (50 ms) early to QRS onset; right panel shows pace-map from proximal septal perforator; inset representative wire
position on coronary angiogram with ablator at earliest endocardial site.
Fig. 3. Electroanatomical mapping of the right and left ventricle for patient 1 (the blue sphere represents the earliest activation point and as shown in electrogram is only just (5 ms)
pre QRS onset). The ﬁgure on the right depicts coronary sinus venogram with ablator at the early site.
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truncated 3rd septal perforator. The day following the procedure,VPCs had not been detected on telemetry and repeat transthoracic
echocardiography showed normal LV function. On repeat Holter
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clinical follow-up the patient has been asymptomatic.
In patient 2 activation mapping of the VPCs from the endocar-
dium and within the coronary sinus revealed an earliest site in
approximation to the bundle of His. However, it was only just on
time with the VPC QRS onset. Coronary angiography showed
normal coronary arteries and intracoronary mapping was per-
formed. The VPC electrograms from the second septal perforator
were 15 ms pre-VPC QRS onset. After inﬂation of the OTW balloon,
1.5mL of ethanol was injected down this branch and the balloon
was left inﬂated for 5 min. Ethanol injection resulted in transient ST
elevation in the septal leads and elimination of VPCs. The patient
represented with ventricular ectopy of the same morphology
within 48 hours and underwent a further EPS and intra-coronary
mapping. During this procedure, when the BMW guidewire was
passed down the ﬁrst septal perforator, VT with a morphology
identical to the clinical VPC was induced. The unipolar electrogram
had a QSmorphology and VTwas terminated by cold saline injected
down the inﬂated OTW balloon (Fig. 2). Pace mapping revealed a
good match to the clinical ectopic (Fig. 2). After contrast injection
conﬁrmed balloon occlusion, 1.5mL of ethanol was injected and the
balloon was left inﬂated for 5 minutes, causing transient ST eleva-
tion in the septal leads. The patient had no further ectopy and was
discharged the following day. At follow-up of 16months the patient
has had no further ventricular ectopy on clinical review or Holter
monitoring.
3. Discussion
3.1. Ventricular premature contractions
A high burden of VPCs may be associated with incident reduc-
tion in left ventricular function, congestive heart failure and
increased mortality [2]. Consensus guidelines recommend catheter
ablation of VPCs should be considered for patients who are highly
symptomatic or where a high VPC burden (at least 10% on 24hour
monitoring) is associated with a reduction in ejection fraction [1].
The two patients in the present study had preserved left ventricular
function despite a high burden of ventricular ectopy. The risk of
VPC-induced cardiomyopathy does not have a linear relationship
with VPC burden. We hypothesise that the septal site of origin (and
accordingly narrow QRS duration) may in part explain the pre-
served ventricular function in the present study. Although 74e100%
of patients are reported to have elimination of VPCs with ablation,
the success rate is reduced where the VPC origin has an epicardial
coronary venous origin [1] and is probably further reduced in pa-
tients with an intramural focus. The reduced success of ablation for
intramural VPCs is reﬂected in this series as both patients had
undergone failed endocardial and epicardial ablation procedures
prior to ethanol ablation.
3.2. Ethanol ablation
More than thirty years ago Brugada and colleagues demon-
strated the utility of transcoronary ethanol ablation for patients
with ventricular tachycardia. While there have been reports of
ethanol ablation for VPCs in the setting of compromised LV function
[5], we are unaware of a series of patients with VPCs in the setting
of normal ventricular function who have required ethanol ablation
due to severe symptoms coupled with an intramural VPC source.
Both of our patients had trialled multiple medications to sup-
press the VPCs, and this is in keeping with studies suggesting only
10e15% of patients will have >90% suppression of VPCs with
medications alone [1].3.3. Success of ethanol ablation
Neither patient in the present report has had a recurrence of
VPCs at follow-up of 6 and 16months after one and two procedures
respectively off anti-arrhythmicmedication. Kumar et al. reported a
series of 46 patients with ventricular arrhythmias where ethanol
ablation was attempted (including 8 patients unsuitable for the
procedure who did not receive ethanol ablation), noting that a
majority of these procedures were for ventricular tachycardia [5].
The 12-month freedom from ventricular arrhythmia in that series
after ethanol ablation of ventricular tachycardia was 82%. The
success of ethanol ablation is dependent on identifying the perfo-
rator supplying the ectopic focus, and is well reﬂected in this report
as the 2nd patient had an initially unsuccessful ethanol ablation
procedure as the incorrect septal perforator was identiﬁed with
wire mapping at ﬁrst procedure.3.4. Risks of ethanol ablation
Permanent AV block has been reported in the initial reports
identifying the role of this technique for treatment of ventricular
tachycardia, and may occur even without prolongation of the AH
interval on cold saline injection [4]. In the series by Kumar et al. 32%
of patients experienced a complication, with the majority being AV
block (18%), and single cases of contrast nephropathy, stroke,
cholesterol embolization, hypotension requiring balloon pump and
coronary vasospasm; there was one procedure related death (2.8%)
[5]. Due to the signiﬁcant risks of ethanol ablation the procedure
should be reserved for the most symptomatic patients who have
undergone unsuccessful endocardial and/or epicardial ablation.4. Conclusion
Symptomatic ventricular premature contractions associated
with preserved ventricular function are amenable to intracoronary
ethanol ablation where attempts to map and ablate the focus from
the endocardium and epicardium have been unsuccessful and
suggest an intramural focus.Funding sources
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